)
Edge20 Feb 2026
Dollar General: The Rural Retailer Playbook
How Dollar General built a small-box empire across rural America, scaling value and convenience into one of retail's most durable business models.
BioArctic
BioArctic (BIOA) investor relations material
BioArctic Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary18 Feb, 2026
Executive summary
Achieved record financial results in 2025, marking a transformative year with significant revenue and profit growth, driven by strong demand for Leqembi and expansion of the innovation pipeline.
Leqembi established as a leading Alzheimer's treatment, approved in 53 countries, with expanded indications, new formulations, and significant regulatory progress.
Broadened pipeline with new candidate drugs in ALS, Parkinson's, Huntington's, and synucleinopathies, advancing to preclinical and clinical development.
Entered new global partnerships with Eisai, Bristol Myers Squibb, and Novartis, enhancing financial and R&D capabilities.
Advanced BrainTransporter technology, demonstrating improved brain delivery and attracting strong partner interest.
Financial highlights
Full-year net revenues surged to SEK 2.0 billion, up from 257.4 million, with recurring revenue of SEK 520 million.
Q4 net revenues were SEK 184 million, with SEK 127 million in royalties and SEK 51 million from Novartis upfront payments.
Operating profit for the year was SEK 1,258.8 million, with a strong cash position of SEK 2.2 billion at year-end.
Board proposed a dividend of SEK 2 per share for 2025.
Operating margin for Q4 was 18.1%; full-year margin was 63%.
Outlook and guidance
R&D and operating costs are expected to increase by 50%-70% in 2026 as the project portfolio expands, especially in exidavnemab and new candidate drugs.
Recurring revenues and milestone payments from Leqembi and new launches are expected to continue funding operations and drive further growth.
Commercial milestone for Leqembi expected in 2026, likely exceeding previous EUR 10 million milestone.
The company aims to continue investing in R&D and pursue new strategic partnerships.
Leqembi Europe: How to accelerate market access?
Brain Transporter: Broaden platform beyond antibodies?
Revenue growth: Reliance on royalties vs. milestones?
Leqembi Nordic reimbursement strategy
BT platform: internal programs vs pharma application
Drivers of 2026 R&D cost increase
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next BioArctic earnings date
Q1 202620 May, 2026
BioArctic
Next BioArctic earnings date
Q1 202620 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
BioArctic AB is a research intensive biopharmaceutical company focusing on disease modifying treatments and reliable biomarkers and diagnostics for neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease. BioArctic focuses on innovative treatments in areas with high unmet medical needs. The company was founded in 1993 based on scientific research from Uppsala University, Sweden. Collaborations with universities are of great importance to the company together with our strategically important global partners in the Alzheimer and Parkinson projects.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage